OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma
Nicolás A. Fraunhoffer, Pascal Hammel, Thierry Conroy, et al.
Annals of Oncology (2024) Vol. 35, Iss. 9, pp. 780-791
Open Access | Times Cited: 7

Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens
Hao Chi, Lanqian Su, Yalan Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Functional Genomics and Network Biology
Amit Joshi, Ajay Kumar, Vikas Kaushik
Advances in Bioinformatics (2024), pp. 71-96
Closed Access | Times Cited: 2

Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma
Haoran Zheng, Yimeng Li, Yujia Zhao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer
Samanta N. Gancedo, Ana Sahores, N. Gómez, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Xiao Chai Hu Tang alleviates the pancreatic tumorigenesis via improving the mtDNA N6-Methyladenine modification mediated mitochondrial dysfunction in Syrian hamster model
Jun Cai, Wenyuan Shen, Guixian Zhang, et al.
Phytomedicine (2023) Vol. 116, pp. 154840-154840
Closed Access | Times Cited: 4

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
Nicolás A. Fraunhoffer, Aura I. Moreno Vega, Analía Meilerman Abuelafia, et al.
EBioMedicine (2023) Vol. 92, pp. 104602-104602
Open Access | Times Cited: 3

Patient-Derived-Xenografts in Mice: A Preclinical Platform for Cancer Research
Emiliano Cocco, Elisa de Stanchina
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 7, pp. a041381-a041381
Closed Access | Times Cited: 2

Molecular profiling and mutational landscape: Possible implications in personalized medicine for treatment of pancreatic cancer
Rama Rao Malla, Ganji Purnachandra Nagaraju
Elsevier eBooks (2024), pp. 1-16
Closed Access

Integrating OMICS-based platforms and analytical tools for diagnosis and management of pancreatic cancer: a review
Patrícia Sousa, Laurentina Silva, José S. Câmara, et al.
Molecular Omics (2024)
Closed Access

Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma
Wiktoria Izdebska, Jarosław Daniluk, Jacek Nikliński
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5643-5643
Open Access | Times Cited: 1

Page 1

Scroll to top